# data[].attributes.body
This device is a new innovation for improving life quality for those who have severe aortic disease. As described on the website, Newheartvalve.com, many individuals live asymptomatically with this disease and often options are limited when they become symptomatic. Severe aortic stenosis contributes to a shortened life expectancy (2-5 years) and creates a myriad of multi-system problems ("Aortic Stenosis Facts", 2016) This innovation is improving patient outcomes for those without options and is designed for ease of insertion via 3 approaches. This is a time saving device for the surgeon and the patient. This procedure will contribute to cost savings by shortening surgical time, reducing post procedure hospital length of stay, and reducing individual future medical costs!

# data[].attributes.body
This is a great innovation because it is providing treatment options for patients who are in a high risk category who have severe systemic disease.  Many benefits to this device are providing patients with an increased chance of survival and better quality of life. This treatment option for severe aortic stenosis is a choice for those too sick for major open heart procedure for aortic valve replacement.

# data[].attributes.body
Newheartvalve.com is a contributed affiliated website product promotion from Edwards Lifesciences Corporation.

The YouTube channel sponsored by Edwards Lifesciences provides education on the heart valve covering full risks and benefits.

# data[].attributes.body
1. High risk for stroke
2. Life of valve not established.
3. Limited to patients only able  to take anticoagulants.
4. Long term durability has not been established.

# data[].attributes.attachment_link.entities[].name
Edwards SAPIEN Transcatheter Heart Valve

# data[].attributes.attachment_link.entities[].name
Transcatheter Aortic Valve Implantation | Nucleus Health

# data[].attributes.attachment_link.authors[].name
Transcatheter Aortic Valve Replacement (TAVR) Information

# data[].attributes.attachment_link.title
TAVR: Transcatheter Aortic Valve Replacement (TAVR) - Transfemoral Approach

# data[].attributes.attachment_link.description
TAVR is a treatment option for certain patients who have severe aortic stenosis but are high-risk or too sick for open heart surgery. Please talk to a Heart Team to determine which treatment option is right for you. This animated video shows an anatomical overview of what happens during TAVR's transfemoral approach, which is performed through an incision in your leg.

# data[].attributes.body
1. Low operative mortality rate
2. Provides treatment for the advanced aged, left ventricular dysfunction, and existance of multiple co-morbities.
3. Faster recovery time
4. Shorter surgery time
5. Cost savings
6. Improved patient life quality

# data[].attributes.body
References

About the TAVR Procedure. (2016). Retrieved from https://newheartvalve.com/hcp/tavr-overview

Aortic Stenosis Facts. (2016). Retrieved from https://newheartvalve.com/hcp/severe-aortic-stenosis-treatment-options

Davies Jr., J. E., McAlexander, W.W., Sasse, M.F., Leesar, M.A., Melby, S.J., Singh, S.P., . . . Alli, O.O., (2016, April ). Impact of

trancatheter aortic valve replacement on surgical volumes and outcomes in a tertiary academic cardiac surgical practice.

Journal of the American College of Surgeons. 222 (4), 645-655.

Leon, M.B., Smith C.R., Mack, M., Miller, C., Moses, J.W., Svensson, L.G., . . . Pocock, S. (2010, October 21). Transcatheter aortic-

valve implantation for aortic stenosis in patients who cannot undergo surgery. The New England Journal of Medicine. 363 (17)

597-1607. doi: 10.1056/NEJMoa1008232

Nissen, S. (2015, February 9).  3 heart disease treatment breakthroughs that are changing lives. Retrieved from

http://www.everydayhealth.com/columns/health-answers/hope-for-heart-disease-patients-three-medical-breakthroughs

Transcatheter Aortic Valve Replacement (TAVR) Information. (2015, July 9). TAVR: Transcatheter aortic valve replacement (TAVR) -

transfemoral approach [ Video file ]. Retrieved from https://youtu.be/eS7mbXHDNn0

Treatment Options. (2016). Retrieved from https://newheartvalve.com/hcp/severe-aortic-stenosis-treatment-options

# data[].attributes.body
Transfemoral, transapical, and transaortic approaches allow the surgeon to introduce a sheath for entry access for ballooning of the aortic diseased aortic valve leaflets and implant the new prosthetic valve ("About the TAVR Procedure", 2016).

# data[].attributes.body
A Close Look at the Implant
The Edwards Sapient XT is an heart valve made of animal tissue and comes in three sizes (23mm, 26mm, 29mm).
https://newheartvalve.com/files/SAPIEN_XT_Valve-in-Valve_Patient_Brochure.pdf

# data[].attributes.headline
Summary - Transcatheter Aortic Valve Replacement 

# data[].attributes.subject
Summary - Transcatheter Aortic Valve Replacement 

# data[].attributes.body
In 2011, the FDA approved this new procedure for aortic valve replacement ("Treatment options", 2016). This surgical innovation approach for aortic stenosis is either referred to transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation (TAVI), and can be performed in 3 different approaches that is minimally invasive for the patient ("Treatment Options", 2016). These less invasive surgical options are ideal for those patients who suffer from severe aortic stenosis who are high risk surgical candidates. This procedure balloons the native diseased valve first and implants the new heart valve at the aortic valve site via catheter guide approach (Leon et al., 2010).